{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5b0fd1107b67904376d520f7/602656da17ed4f1cbbac4323?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Advanced Oncotherapy: Democratising Proton Beam Therapy in cancer treatment","description":"<p>The UK Investor Magazine Podcast was joined by Nicolas Serandour, CEO of Advanced Oncotherapy, to discuss the latest progress in democratising Proton Beam Therapy. </p><p><br></p><p>Nicolas explains the benefits of Proton Beam Therapy&nbsp;when compared to radiotherapy in treating certain forms of cancers and how Advanced Oncotherapy is setting out to make the treatment available to more patients.</p><p><br></p><p>There is also consideration paid to Advanced Oncotherapy's revenue channels and recent technical trading update.  </p><p><br></p>","author_name":"UK Investor Magazine"}